Clinical trials
15 active studies led by Luye Pharma Group Ltd., of 74 in all
Source: ClinicalTrials.gov, Studies with Luye Pharma Group Ltd. (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
- 0Reports naming them
- 3Markets in public records
- 0Regions & countries
- 15Active trials they lead[1]
[1] ClinicalTrials.gov, Studies led by Luye Pharma Group Ltd. or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
Free public data on Luye Pharma Group Ltd.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
See them on ClinicalTrials.gov (opens in a new tab)
Trials over time
Studies Luye Pharma Group Ltd. leads, by the year they started and their phase
- Phase 1
- Phase 2
- Phase 3
- Phase 4
- No phase (devices, observational)
Source: ClinicalTrials.gov, Studies with Luye Pharma Group Ltd. or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets where public records show them
Markets we cover where free public records show Luye Pharma Group Ltd.: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
Topics
The topics of the markets Luye Pharma Group Ltd. is in.
From our blog
Stories on the topics Luye Pharma Group Ltd. works in.
Adaptogens: Ancient Herbs, Modern Market
170 WHO Member States report the use of traditional medicine. Adaptogens like ashwagandha, rhodiola and…
Read
Stress and Mood Supplements: Ashwagandha and Beyond
Depression and anxiety cost the world about US$1 trillion a year. Ashwagandha has some evidence for stress…
Read
Brain Cancer Diagnosis: Imaging and New Biomarkers
About 321,000 people were diagnosed with brain and nervous system tumours in 2022, and about 248,000 died…
Read